Evidence map›Paper›PMID 40747240›Full record

ArticleClinical kidney journal2025

Long-term impact of PM

Soie Kwon, Hyunman Sim, Ara Ko, Whanhee Lee, Ho Kim, Seung Hyun Han, Hyeon Seok Hwang, Dong Ki Kim, Chun Soo Lim, Yon Su Kim and 2 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Soie KwonDepartment of Internal Medicine, Chung-Ang University Seoul Hospital, Seoul, Republic of Korea.
Hyunman SimDepartment of Public Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea.ORCID https://orcid.org/0009-0000-4769-4749
Ara KoDepartment of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea.
Whanhee LeeSchool of Biomedical Convergence Engineering, Pusan National University, Yangsan, Republic of Korea.
Ho KimDepartment of Public Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0001-7472-3752
Seung Hyun HanDepartment of Internal Medicine, Division of Nephrology, Inje University, Ilsan-Paik Hospital, Goyang, Republic of Korea.ORCID https://orcid.org/0000-0001-5132-5452
Hyeon Seok HwangDepartment of Internal Medicine, Kyung Hee University Hospital, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0002-6356-4933
Dong Ki KimDepartment of Internal Medicine, Seoul National Hospital, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0002-5195-7852
Chun Soo LimDepartment of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea.
Yon Su KimDepartment of Internal Medicine, Seoul National Hospital, Seoul, Republic of Korea.
Jung Pyo LeeDepartment of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Korea.
Woojoo LeeDepartment of Public Health Sciences, Graduate School of Public Health, Seoul National University, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0001-7447-7045

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ambient air pollutants adversely affect renal function and increase type 2 diabetes incidence. However, the impact of air pollution on diabetic kidney disease (DKD) patients remains underexplored, with limited consideration of medication-related effects. We assessed the influence of air pollutants on DKD patients while meticulously adjusting for medication use. Methods: We retrospectively enrolled DKD patients. Primary and secondary outcomes included end-stage kidney disease (ESKD) and a composite (ESKD and mortality). Nationwide forecasted ultra-high-resolution air pollutant data [2.5-μm particulate matter (PM Results: Patients ( Conclusion: Even after comprehensive medication use adjustment, higher PM

Indexed as

chronic kidney diseasediabetic kidney diseaseend-stage kidney diseasePM2.5

Identifiers

PMID40747240
PMCPMC12311423

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.